RadNet, Inc. (RDNT)
USD 72.41
(-5.37%)
USD 72.41
(-5.37%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.49 Billion USD | -1.48% |
| 2022 | 1.51 Billion USD | 8.28% |
| 2021 | 1.39 Billion USD | 17.97% |
| 2020 | 1.18 Billion USD | 0.33% |
| 2019 | 1.18 Billion USD | 75.68% |
| 2018 | 672.27 Million USD | 10.37% |
| 2017 | 609.12 Million USD | -4.63% |
| 2016 | 638.73 Million USD | -0.31% |
| 2015 | 640.72 Million USD | 7.22% |
| 2014 | 597.6 Million USD | 2.75% |
| 2013 | 581.62 Million USD | -0.13% |
| 2012 | 582.4 Million USD | 4.22% |
| 2011 | 558.82 Million USD | 10.75% |
| 2010 | 504.57 Million USD | 11.8% |
| 2009 | 451.31 Million USD | -3.21% |
| 2008 | 466.28 Million USD | 10.54% |
| 2007 | 421.8 Million USD | 131.87% |
| 2006 | 181.91 Million USD | 19.21% |
| 2005 | 152.6 Million USD | -9.86% |
| 2004 | 169.28 Million USD | 2.14% |
| 2003 | 165.74 Million USD | 4.52% |
| 2002 | 158.58 Million USD | 7.52% |
| 2001 | 147.49 Million USD | 10.64% |
| 2000 | 133.3 Million USD | 11.84% |
| 1999 | 119.2 Million USD | 13.09% |
| 1998 | 105.39 Million USD | 8.1% |
| 1997 | 97.5 Million USD | -14.41% |
| 1996 | 113.91 Million USD | 58.98% |
| 1995 | 71.65 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 1.52 Billion USD | 2.15% |
| 2024 Q2 | 1.71 Billion USD | 12.81% |
| 2023 Q1 | 1.55 Billion USD | 2.44% |
| 2023 FY | 1.49 Billion USD | -1.48% |
| 2023 Q4 | 1.49 Billion USD | -2.78% |
| 2023 Q2 | 1.55 Billion USD | 0.15% |
| 2023 Q3 | 1.53 Billion USD | -1.22% |
| 2022 Q4 | 1.51 Billion USD | 5.22% |
| 2022 FY | 1.51 Billion USD | 8.28% |
| 2022 Q3 | 1.43 Billion USD | -0.45% |
| 2022 Q2 | 1.44 Billion USD | 2.67% |
| 2022 Q1 | 1.4 Billion USD | 0.69% |
| 2021 FY | 1.39 Billion USD | 17.97% |
| 2021 Q4 | 1.39 Billion USD | 1.2% |
| 2021 Q3 | 1.38 Billion USD | -1.27% |
| 2021 Q1 | 1.21 Billion USD | 2.94% |
| 2021 Q2 | 1.39 Billion USD | 14.69% |
| 2020 Q2 | 1.17 Billion USD | -5.58% |
| 2020 FY | 1.18 Billion USD | 0.33% |
| 2020 Q1 | 1.24 Billion USD | 5.0% |
| 2020 Q4 | 1.18 Billion USD | 1.58% |
| 2020 Q3 | 1.16 Billion USD | -0.38% |
| 2019 Q1 | 1.11 Billion USD | 65.9% |
| 2019 FY | 1.18 Billion USD | 75.68% |
| 2019 Q2 | 1.19 Billion USD | 6.79% |
| 2019 Q3 | 1.19 Billion USD | -0.02% |
| 2019 Q4 | 1.18 Billion USD | -0.81% |
| 2018 Q4 | 672.27 Million USD | 14.66% |
| 2018 FY | 672.27 Million USD | 10.37% |
| 2018 Q1 | 603.98 Million USD | -0.84% |
| 2018 Q2 | 594.89 Million USD | -1.5% |
| 2018 Q3 | 586.34 Million USD | -1.44% |
| 2017 FY | 609.12 Million USD | -4.63% |
| 2017 Q4 | 609.12 Million USD | -1.43% |
| 2017 Q3 | 617.94 Million USD | -1.75% |
| 2017 Q2 | 628.96 Million USD | -1.08% |
| 2017 Q1 | 635.85 Million USD | -0.45% |
| 2016 Q3 | 648.39 Million USD | 1.79% |
| 2016 Q4 | 638.73 Million USD | -1.49% |
| 2016 Q2 | 637 Million USD | -1.68% |
| 2016 Q1 | 647.88 Million USD | 1.12% |
| 2016 FY | 638.73 Million USD | -0.31% |
| 2015 Q1 | 600.51 Million USD | 0.49% |
| 2015 Q2 | 646.65 Million USD | 7.68% |
| 2015 Q4 | 640.72 Million USD | -0.86% |
| 2015 FY | 640.72 Million USD | 7.22% |
| 2015 Q3 | 646.31 Million USD | -0.05% |
| 2014 Q3 | 613.85 Million USD | 0.22% |
| 2014 FY | 597.6 Million USD | 2.75% |
| 2014 Q4 | 597.6 Million USD | -2.65% |
| 2014 Q2 | 612.51 Million USD | -1.97% |
| 2014 Q1 | 624.83 Million USD | 7.43% |
| 2013 Q2 | 583.74 Million USD | -0.05% |
| 2013 Q4 | 581.62 Million USD | -0.49% |
| 2013 FY | 581.62 Million USD | -0.13% |
| 2013 Q1 | 584.01 Million USD | 0.28% |
| 2013 Q3 | 584.5 Million USD | 0.13% |
| 2012 FY | 582.4 Million USD | 4.22% |
| 2012 Q3 | 551.27 Million USD | -0.48% |
| 2012 Q2 | 553.93 Million USD | -0.59% |
| 2012 Q1 | 557.24 Million USD | -0.28% |
| 2012 Q4 | 582.4 Million USD | 5.65% |
| 2011 Q1 | 514.06 Million USD | 1.88% |
| 2011 Q3 | 523.94 Million USD | 0.51% |
| 2011 FY | 558.82 Million USD | 10.75% |
| 2011 Q4 | 558.82 Million USD | 6.66% |
| 2011 Q2 | 521.3 Million USD | 1.41% |
| 2010 Q2 | 510.42 Million USD | 14.49% |
| 2010 Q3 | 505.51 Million USD | -0.96% |
| 2010 FY | 504.57 Million USD | 11.8% |
| 2010 Q4 | 504.57 Million USD | -0.19% |
| 2010 Q1 | 445.8 Million USD | -1.22% |
| 2009 Q3 | 457.29 Million USD | -1.6% |
| 2009 Q4 | 451.31 Million USD | -1.31% |
| 2009 Q1 | 469.51 Million USD | 0.69% |
| 2009 Q2 | 464.71 Million USD | -1.02% |
| 2009 FY | 451.31 Million USD | -3.21% |
| 2008 Q2 | 477.97 Million USD | 0.36% |
| 2008 FY | 466.28 Million USD | 10.54% |
| 2008 Q3 | 480.09 Million USD | 0.44% |
| 2008 Q4 | 466.28 Million USD | -2.88% |
| 2008 Q1 | 476.27 Million USD | 12.91% |
| 2007 Q2 | 384.29 Million USD | 0.64% |
| 2007 Q1 | 381.86 Million USD | 0.0% |
| 2007 Q3 | 417.76 Million USD | 8.71% |
| 2007 Q4 | 421.8 Million USD | 0.97% |
| 2007 FY | 421.8 Million USD | 131.87% |
| 2006 Q3 | 181.91 Million USD | 4.29% |
| 2006 FY | 181.91 Million USD | 19.21% |
| 2006 Q2 | 174.43 Million USD | 2.92% |
| 2006 Q1 | 169.48 Million USD | 4.48% |
| 2005 Q3 | 152.6 Million USD | -8.25% |
| 2005 FY | 152.6 Million USD | -9.86% |
| 2005 Q4 | 162.21 Million USD | 6.3% |
| 2005 Q2 | 166.31 Million USD | -2.46% |
| 2005 Q1 | 170.51 Million USD | 0.88% |
| 2004 Q4 | 169.01 Million USD | -0.16% |
| 2004 Q1 | 169.9 Million USD | -1.18% |
| 2004 Q3 | 169.28 Million USD | 0.4% |
| 2004 Q2 | 168.61 Million USD | -0.76% |
| 2004 FY | 169.28 Million USD | 2.14% |
| 2003 Q2 | 170.1 Million USD | -3.37% |
| 2003 FY | 165.74 Million USD | 4.52% |
| 2003 Q3 | 165.74 Million USD | -2.56% |
| 2003 Q1 | 176.03 Million USD | -1.84% |
| 2003 Q4 | 171.93 Million USD | 3.73% |
| 2002 FY | 158.58 Million USD | 7.52% |
| 2002 Q4 | 179.33 Million USD | 13.08% |
| 2002 Q3 | 158.58 Million USD | -7.31% |
| 2002 Q2 | 171.09 Million USD | 2.76% |
| 2002 Q1 | 166.49 Million USD | 5.33% |
| 2001 Q1 | 124.69 Million USD | -1.61% |
| 2001 FY | 147.49 Million USD | 10.64% |
| 2001 Q4 | 158.06 Million USD | 7.17% |
| 2001 Q3 | 147.49 Million USD | 11.26% |
| 2001 Q2 | 132.56 Million USD | 6.31% |
| 2000 Q1 | 123.1 Million USD | 2.16% |
| 2000 Q4 | 126.73 Million USD | -4.93% |
| 2000 Q3 | 133.3 Million USD | 0.79% |
| 2000 Q2 | 132.26 Million USD | 7.44% |
| 2000 FY | 133.3 Million USD | 11.84% |
| 1999 Q1 | 79.9 Million USD | -1.84% |
| 1999 Q4 | 120.5 Million USD | 3.17% |
| 1999 FY | 119.2 Million USD | 13.09% |
| 1999 Q3 | 116.8 Million USD | 48.41% |
| 1999 Q2 | 78.7 Million USD | -1.5% |
| 1998 FY | 105.39 Million USD | 8.1% |
| 1998 Q3 | 77.9 Million USD | 6.86% |
| 1998 Q2 | 72.9 Million USD | 1.53% |
| 1998 Q1 | 71.8 Million USD | -1.91% |
| 1998 Q4 | 81.4 Million USD | 4.49% |
| 1997 Q1 | 80 Million USD | -7.08% |
| 1997 FY | 97.5 Million USD | -14.41% |
| 1997 Q4 | 73.2 Million USD | -2.53% |
| 1997 Q2 | 78.3 Million USD | -2.13% |
| 1997 Q3 | 75.1 Million USD | -4.09% |
| 1996 Q4 | 86.1 Million USD | 2.01% |
| 1996 Q3 | 84.4 Million USD | 20.06% |
| 1996 FY | 113.91 Million USD | 58.98% |
| 1996 Q2 | 70.3 Million USD | -0.71% |
| 1996 Q1 | 70.8 Million USD | 0.0% |
| 1995 FY | 71.65 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Bionano Genomics, Inc. | 87.94 Million USD | -1595.476% |
| Prenetics Global Limited | 2.36 Million USD | -62832.707% |
| Star Equity Holdings, Inc. | 3.6 Million USD | -41216.708% |
| CareDx, Inc | 34.22 Million USD | -4257.324% |
| Exact Sciences Corporation | 2.55 Billion USD | 41.633% |
| Exagen Inc. | 23.72 Million USD | -6186.076% |
| Inotiv, Inc. | 417.64 Million USD | -257.034% |
| Guardant Health, Inc. | 1.35 Billion USD | -10.146% |
| Biodesix, Inc. | 60.69 Million USD | -2356.905% |
| BioNexus Gene Lab Corp. | 133.39 Thousand USD | -1117723.007% |
| Precipio, Inc. | 1.11 Million USD | -133512.903% |
| iSpecimen Inc. | 196.24 Thousand USD | -759729.6% |
| Natera, Inc. | 441.99 Million USD | -237.363% |
| Aspira Women's Health Inc. | 2.26 Million USD | -65704.06% |
| Standard BioTools Inc. | 98.21 Million USD | -1418.298% |
| 23andMe Holding Co. | 76.51 Million USD | -1848.794% |
| Castle Biosciences, Inc. | 15.31 Million USD | -9639.517% |
| Personalis, Inc. | 48.96 Million USD | -2945.464% |
| Aclaris Therapeutics, Inc. | 426 Thousand USD | -349928.169% |
| Applied DNA Sciences, Inc. | 1.23 Million USD | -120369.235% |
| OpGen, Inc. | 13.04 Million USD | -11331.72% |
| T2 Biosystems, Inc. | 49.49 Million USD | -2912.485% |
| Myriad Genetics, Inc. | 145 Million USD | -928.359% |
| ICON Public Limited Company | 3.93 Billion USD | 62.138% |
| NeoGenomics, Inc. | 611.67 Million USD | -143.775% |
| Star Equity Holdings, Inc. | 3.6 Million USD | -41216.708% |
| IDEXX Laboratories, Inc. | 947.88 Million USD | -57.311% |
| MDxHealth SA | 41.26 Million USD | -3513.522% |
| Psychemedics Corporation | 2.29 Million USD | -64787.728% |
| Illumina, Inc. | 2.26 Billion USD | 34.08% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Twist Bioscience Corporation | 94.06 Million USD | -1485.134% |
| DarioHealth Corp. | 29.54 Million USD | -4947.629% |
| Fulgent Genetics, Inc. | 14.9 Million USD | -9902.817% |
| Sera Prognostics, Inc. | 1.85 Million USD | -80154.037% |
| ENDRA Life Sciences Inc. | 394.4 Thousand USD | -377970.147% |
| OPKO Health, Inc. | 326.56 Million USD | -356.609% |
| Medpace Holdings, Inc. | 142.12 Million USD | -949.183% |
| Neogen Corporation | 906.23 Million USD | -64.539% |
| Intelligent Bio Solutions Inc. | 871.44 Thousand USD | -171009.887% |
| Prenetics Global Limited | 2.36 Million USD | -62832.707% |
| Mainz Biomed B.V. | 7.42 Million USD | -19993.845% |
| bioAffinity Technologies, Inc. | 1.57 Million USD | -94356.047% |
| Trinity Biotech plc | 67.42 Million USD | -2111.458% |
| Neuronetics, Inc. | 62.47 Million USD | -2286.785% |
| Sotera Health Company | 2.32 Billion USD | 35.922% |
| bioAffinity Technologies, Inc. | 1.57 Million USD | -94356.047% |